Contribution: Industrial Research Assistance Program – Contributions to Firms
Mediphage Bioceuticals, Inc.
$125,000.00
Scale-up and Optimization of Linear Covalently Closed DNA Ministrings (msDNA) Production
FY 2019-20 · 2019-07-15
Summary
This project will enable large-scale production of ministring DNA transgene delivery vector by improving fermentation and purification efficiency. Increased production capacity will support Mediphage's genetic medicine program.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
788308328
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2020-07-31
Agreement Number
933784
Agreement Start Date
2019-07-15
Agreement Title
Scale-up and Optimization of Linear Covalently Closed DNA Ministrings (msDNA) Production
Agreement Title (French)
Mise à l'échelle et optimisation de la production de minicordes d'ADN linéaire fermées par covalence
Agreement Type
Contribution
Agreement Value
$125,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will enable large-scale production of ministring DNA transgene delivery vector by improving fermentation and purification efficiency. Increased production capacity will support Mediphage's genetic medicine program.
Description (French)
Ce projet permettra la production à grande échelle de vectrice minicorde d'ADN transgénique en améliorant l'efficacité de la fermentation et de la purification. L'augmentation de la capacité de production appuiera le programme de médecine génétique de Mediphage.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
University--Rosedale
Federal Riding (French)
University--Rosedale
Federal Riding Number
35110
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
788308328
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Mediphage Bioceuticals, Inc.
Recipient Postal Code
M5G 0B7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2019-2020-Q2-933784
